Milissa Davis
Psychiatric/Mental Health · Columbia, SCNPI 1558992701
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 24.1% of the total. 2025 is the largest year on record at $2,044, more than ten times the $126 reported in 2021.
Across 201 payments — averaging $22.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Neurocrine Biosciences, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$616
- Otsuka America Pharmaceutical, Inc.$572
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$334
- Supernus Pharmaceuticals, Inc.$328
- plus $631 from 7 others
What the payments were for
- Food & beverage$4,48397%
- Education$1163%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,108 |
| Neurocrine Biosciences, Inc. | 35 | $1,010 |
| Teva Pharmaceuticals USA, Inc. | 19 | $616 |
| Otsuka America Pharmaceutical, Inc. | 18 | $572 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $334 |
| Supernus Pharmaceuticals, Inc. | 10 | $328 |
| Vanda Pharmaceuticals Inc. | 5 | $205 |
| Alkermes, Inc. | 5 | $160 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Lundbeck LLC | 5 | $92 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| Indivior Inc. | 1 | $17 |
| Corium, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$426
- INGREZZA$373
- VRAYLAR$250
- Austedo XR$247
- QELBREE$180
- ABILIFY MAINTENA$124
- REXULTI$124
- Auvelity$120
- UZEDY$120
- Fanapt$118
How this compares
$4,600 in reported general payments places this provider in the 85th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $104,762 |
| RexultiBrexpiprazole | 11 | $36,276 |
| VraylarCariprazine Hcl | 13 | $17,525 |
| TrintellixVortioxetine Hydrobromide | 15 | $10,867 |
| Buspirone Hcl | 78 | $1,278 |
| Hydroxyzine Pamoate | 47 | $939 |
| Olanzapine OdtOlanzapine | 12 | $496 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 44 | $390 |
| Fluoxetine Hcl | 44 | $384 |
| Propranolol Hcl | 25 | $378 |
| Lamotrigine | 31 | $373 |
| Duloxetine Hcl | 22 | $366 |
| Sertraline Hcl | 46 | $356 |
| Olanzapine | 22 | $340 |
| Trazodone Hcl | 56 | $337 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $1,010 | $104,76213 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $572 | $36,27611 claims |
| AbbVieVraylar | $1,108 | $17,52513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 354 psychiatric/mental health providers in South Carolina.
Other psychiatric/mental health in Columbia
- Elizabeth EggebrechtColumbia$11K
- Natalie VerenesColumbia$10K
- April HuttoColumbia$6K
- Penny LoyaColumbia$5K
- Cheryl SuberColumbia$4K
- Henretta MiltonColumbia$4K
- Jennipher Immanuel ManoharColumbia$4K
- Regina HensleyColumbia$3K
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.